Abstract:BACKGROUND: Mitochondrial dysfunction and oxidative stress are closely associated with the pathogenesis of Parkinson's disease. Peroxisome proliferator-activated receptor γ coactivator 1 alpha (PGC-1α) is thought to play multiple roles in the regulation of mitochondrial biogenesis and cellular energy metabolism. We recently reported that altering PGC-1α gene expression modulates mitochondrial functions in N-methyl-4-phenylpyridinium ion (MPP<sup>+</sup>) treated human SH-SY5Y neuroblastoma cells, possibly via the regulation of Estrogen-related receptor α (ERRα), nuclear respiratory factor 1 (NRF-1), nuclear respiratory factor 2 (NRF-2) and peroxisome proliferator-activated receptor γ (PPARγ) expression. In the present study, we aimed to further investigate the potential beneficial effects of PGC-1α in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated C57BL mice.METHODS: The overexpression or knockdown of the PGC-1α gene in the mouse model of dopaminergic neurotoxicity was performed using a stereotactic injection of lentivirus in MPTP-treated male C57BL/6 mice. Mice were randomly assigned to one of 6 groups (n=24 per group): normal saline (NS) intraperitoneal injection (i.p.) (con); MPTP i.p. (M); solvent of the lentivirus striatal injection (lentivirus control) + MPTP i.p. (LVcon+M); lentivirus striatal injection + MPTP i.p. (LV+M); LV-PGC-1α striatum injection + MPTP i.p. (LVPGC+M); and LV-PGC-1α-siRNA striatal injection + MPTP i.p. (LVsiRNA+M). Intraperitoneal injections of MPTP/NS were conducted two weeks after lentivirus injection.RESULTS: We found significant improvement in motor behavior and increases in tyrosine hydroxylase expression in the substantia nigra (SN) in the brains of mice in the LVPGC+M group. The opposite tendency was observed in those in the LVsiRNA+M group. The expression of superoxide dismutase (SOD) in the SN region was also consistent with the changes in PGC-1α expression. Electron microscopy showed an increasing trend in the mitochondrial density in the LVPGC+M group and a decreasing trend in the M and LVsiRNA+M groups compared to that in the controls.CONCLUSIONS: Our results indicated that PGC-1α rescues the effects of MPTP-induced mitochondrial dysfunction in C57BL mice.

Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1- Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in Mice.

Mitochondrial Morphology and Synaptic Structure Altered in the Retina of Parkin-Deficient Mice

Parkin Mutation Decreases Neurite Complexity and Maturation in Neurons Derived from Human Fibroblasts

Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models

Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.

Parkin Overexpression Ameliorates Hippocampal Long-Term Potentiation and -Amyloid Load in an Alzheimer's Disease Mouse Model

Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells.

Parkin Controls Dopamine Utilization in Human Midbrain Dopaminergic Neurons Derived from Induced Pluripotent Stem Cells

Synaptotagmin-11 is a Critical Mediator of Parkin-Linked Neurotoxicity and Parkinson’s Disease-Like Pathology

Parkin Mutations Reduce the Complexity of Neuronal Processes in Ipsc-Derived Human Neurons.

RESP18 deficiency has protective effects in dopaminergic neurons in an MPTP mouse model of Parkinson's disease.

Parkin Ubiquitinates Drp1 for Proteasome-dependent Degradation

Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease

Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity

Parkin Overexpression Attenuates Aβ-induced Mitochondrial Dysfunction in HEK293 Cells by Restoring Impaired Mitophagy.

Inhibition of Mir-421 Preserves Mitochondrial Function and Protects Against Parkinson’s Disease Pathogenesis Via Pink1/Parkin-Dependent Mitophagy

Effect of Neurotoxins on Parkin Mediated Mitochondrial Morphology Regulation

Mitochondrial DNA Instability Supersedes Parkin Mutations in Driving Mitochondrial Proteomic Alterations and Functional Deficits in Polg Mutator Mice

Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair

Inhibition of dynamin-related protein 1 ameliorates the mitochondrial ultrastructure via PINK1 and Parkin in the mice model of Parkinson's disease